Nombre de documents

5

CV de Eddy Pasquier


Article dans une revue5 documents

  • Marie Amélie Heng, Laetitia Padovani, Philippe Dory-Lautrec, Jean Claude Gentet, Arnaud Verschuur, et al.. Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab-irinotecan in children with low-grade glioma?. Cancer Medicine, 2016, 5 (7), pp.1542-1545. <10.1002/cam4.699>. <hal-01478943>
  • Pan Pantziarka, Lisa Hutchinson, Nicolas André, Sébastien Benzekry, Francesco Bertolini, et al.. Next generation metronomic chemotherapy - report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6 - 8 May 2016, Mumbai. Ecancermedicalscience, 2016, 10, <10.3332/ecancer.2016.689>. <hal-01392473>
  • Shripad Banavali, Eddy Pasquier, Nicolas Andre. Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma. Ecancermedicalscience, 2015, 9, <10.3332/ecancer.2015.499>. <hal-01420003>
  • Sébastien Benzekry, Eddy Pasquier, Dominique Barbolosi, Bruno Lacarelle, Fabrice Barlési, et al.. Metronomic Reloaded: Theoretical Models Bringing Chemotherapy into the Era of Precision Medicine. Seminars in Cancer Biology, Elsevier, 2015, pp.23. <10.1016/j.semcancer.2015.09.002>. <hal-01195547>
  • Amine Bazaa, Eddy Pasquier, Céline Defilles, Ines Limam, Raoudha Kessentini-Zouari, et al.. MVL-PLA2, a snake venom phospholipase A2, inhibits angiogenesis through an increase in microtubule dynamics and disorganization of focal adhesions.. PLoS ONE, Public Library of Science, 2010, 5 (4), pp.e10124. <10.1371/journal.pone.0010124>. <pasteur-00604861>